natgillin/translations-raw huggingface dataset:
Brinzolamide is moderately bound (about 60%) to human plasma proteins.
Brinzolamid se zmerno veže na plazemske proteine pri človeku (približno 60%).
Brinzolamide is sequestered in RBCs due to its high affinity binding to CA-II and to a lesser extent to CA-I.
Zaradi velike afinitete za vezavo na CA-II in v manjši meri tudi na CA-I se porazdeli pretežno v eritrocitih.
Brinzolamide was teratogenic in rats, but not rabbits, following systemic administration.
Po sistemski uporabi je bil brinzolamid teratogen pri podganah, ne pa pri kuncih.
Bristol-Myers Squibb Company 6000 Thompson Road, East Syracuse New York 13057 – U.S.A.
Bristol-Myers Squibb Company 6000 Thompson Road, East Syracuse New York 13057 – ZDA
Bristol-Myers Squibb Company Contrada Fontana del Ceraso IT-03012 Anagni (FR)
Bristol-Myers Company Contrada Fontana del Ceraso IT-03012 Anagni (FR)
Bristol-Myers Squibb Pharma EEIG Uxbridge Business Park - Sanderson Road Uxbridge UB8 1DH - United Kingdom
Bristol-Myers Squibb Pharma EEIG Uxbridge Business Park - Sanderson Road Uxbridge UB8 1DH – Velika Britanija
Bristol-Myers Squibb S.R.L. Contrada Fontana del Ceraso 03012 Anagni (FR) - Italy
Bristol-Myers Squibb S.R.L. Contrada Fontana del Ceraso 03012 Anagni (FR) – Italija
bRitonavir oral solution cRitonavir oral solution or capsule/tablet
bRitonavir v obliki peroralne raztopine cRitonavir v obliki peroralne raztopine ali kapsule/tablete
Brittle and
perforacije roženice
Brittle or weak nails
krhki ali lomljivi nohti
Brivaracetam given 50 or 150 mg/day did not affect the AUC of midazolam (metabolised by CYP3A4).
Brivaracetam v odmerku 50 ali 150 mg/dan ni vplival na AUC midazolama (ki ga presnavlja CYP3A4).
Brivaracetam is not recommended in end-stage renal disease patients undergoing dialysis due to lack of data.
Zaradi pomanjkanja podatkov brivaracetam ni priporočen za bolnike s končno ledvično odpovedjo na dializi.
Brivaracetam plasma concentrations may increase when coadministered with CYP2C19 strong inhibitors (e.g. fluconazole, fluvoxamine), but the risk of a clinically relevant CYP2C19-mediated inteaction is considered to be low.
Plazemske koncentracije brivaracetama se lahko povečajo, če se ta daje sočasno z močnimi zaviralci CYP2C19 (npr. flukonazol, fluvoksamin), vendar se tveganje klinično pomembnih interakcij, posredovanih s CYP2C19, smatra za nizko.
Brivaracetam was evaluated in these patients in short term open label pharmacokinetic study and an ongoing open-label extension study, in 152 subjects from 1 month to 16 years of age (see section 5.2).
Brivaracetam so pri teh bolnikih ocenjevali v kratkotrajni odprti študiji farmakokinetike in v odprti podaljšani študiji v teku pri 152 preskušancih, starih od 1 meseca do 16 let (glejte poglavje 5.2).
Brivaracetam was evaluated in these patients in short term open-label pharmacokinetic study and an ongoing open-label extension study, in 152 subjects from 1 month to 16 years of age (see section 5.2).
Brivaracetam so pri teh bolnikih ocenjevali v kratkotrajni odprti študiji farmakokinetike in v odprti podaljšani študiji v teku pri 152 preskušancih, starih od 1 meseca do 16 let (glejte poglavje 5.2).
Briviact
(Izmišljeno) ime
Briviact 10 mg are white to off-white, round, film-coated tablets of 6.5 mm in diameter and debossed with ‘u10’ on one side.
Tablete zdravila Briviact 10 mg so bele do umazano bele, okrogle, filmsko obložene tablete s premerom 6,5 mm in vtisnjeno oznako u10 na eni strani.
Briviact 10 mg/ml (Only for outer carton)
Briviact 10 mg/ml (Samo za škatlo.)
Briviact 10 mg/ml oral solution
Briviact 10 mg/ml peroralna raztopina
Briviact 10 mg/ml oral solution is slightly viscous, clear, colourless to yellowish liquid.
Zdravilo Briviact 10 mg/ml peroralna raztopina je rahlo viskozna, bistra, brezbarvna do rumenkasta tekočina.
Briviact 10 mg/ml solution for injection/infusion is a clear, colourless, sterile solution.
Zdravilo Briviact 10 mg/ml raztopina za injiciranje/infundiranje je bistra, brezbarvna, sterilna raztopina.
Briviact 100 mg are green-grey, oval, film-coated tablets of 14.5 mm x 8.1 mm and debossed with ‘u100’ on one side.
Tablete zdravila Briviact 100 mg so zelenosive, ovalne, filmsko obložene tablete z dimenzijami 14,5 mm x 8,1 mm in vtisnjeno oznako u100 na eni strani.
Briviact 10mg/ml oral solution brivaracetam
Briviact 10 mg/ml peroralna raztopina brivaracetam
Briviact 10mg/ml solution for injection/infusion brivaracetam
Briviact 10 mg/ml raztopina za injiciranje/infundiranje brivaracetam
Briviact 25 mg are grey, oval, film-coated tablets of 8.9 mm x 5.0 mm and debossed with ‘u25’ on one side.
Tablete zdravila Briviact 25 mg so sive, ovalne, filmsko obložene tablete z dimenzijami 8,9 mm x 5,0 mm in vtisnjeno oznako u25 na eni strani.
Briviact 50 mg are yellow, oval, film-coated tablets of 11.7 mm x 6.6 mm and debossed with ‘u50’ on one side.
Tablete zdravila Briviact 50 mg so rumene, ovalne, filmsko obložene tablete z dimenzijami 11,7 mm x 6,6 mm in vtisnjeno oznako u50 na eni strani.
Briviact 75 mg are purple, oval, film-coated tablets of 13.0 mm x 7.3 mm and debossed with ‘u75’ on one side.
Tablete zdravila Briviact 75 mg so škrlatne, ovalne, filmsko obložene tablete z dimenzijami 13,0 mm x 7,3 mm in vtisnjeno oznako u75 na eni strani.
Briviact can be given by injection or by infusion (drip) into a vein if it cannot be given by mouth.
Če zdravila Briviact ni mogoče dajati peroralno, se lahko daje v obliki injekcij ali infuzij (kapalnih infuzij) v veno.
Briviact contains the active substance brivaracetam.
Vsebuje zdravilno učinkovino brivaracetam.
Briviact is available as tablets (10, 25, 50, 75 and 100 mg), an oral solution (10 mg/ml) and a solution for injection or infusion (drip) into a vein (10 mg/ml).
Zdravilo Briviact je na voljo v obliki tablet (10, 25, 50, 75 in 100 mg), peroralne raztopine (10 mg/ml) in raztopine za injiciranje ali infundiranje (kapalna infuzija) v veno (10 mg/ml).
Briviact is indicated as adjunctive therapy in the treatment of partial-onset seizures with or without secondary generalisation in adult and adolescent patients from 16 years of age with epilepsy.
Zdravilo Briviact je indicirano za dopolnilno zdravljenje parcialnih epileptičnih napadov s sekundarno generalizacijo ali brez nje pri odraslih in mladostnikih od 16. leta starosti z epilepsijo.
Briviact is more effective than placebo (a dummy treatment) at reducing seizures.
Zdravilo Briviact je pri zmanjševanju epileptičnih napadov učinkovitejši od placeba (zdravila brez zdravilne učinkovine).
Briviact is not recommended for use in children and young people under 16 years of age.
Zdravila Briviact ne priporočamo za uporabo pri otrocih in mladostnikih, mlajših od 16 let.
Briviact is used in adults and adolescents from 16 years of age to treat a type of epilepsy characterized by the occurrence of partial seizures with or without secondary generalisation’.
Zdravilo Briviact se uporablja za zdravljenje vrste epilepsije, za katero so značilni parcialni napadi s sekundarno generalizacijo ali brez nje, pri odraslih in mladostnikih od 16. leta starosti.
Briviact is used in adults and adolescents from 16 years of age to treat a type of epilepsy characterized by the occurrence of partial seizures with or without secondary generalization’.
Zdravilo Briviact se uporablja za zdravljenje vrste epilepsije, za katero so značilni parcialni napadi s sekundarno generalizacijo ali brez nje, pri odraslih in mladostnikih od 16. leta starosti.
Briviact is used together with other medicines for epilepsy.
Zdravilo Briviact se uporablja skupaj z drugimi zdravili proti epilepsiji.
Briviact may be diluted with the following solutions: sodium chloride 9 mg/ml (0.9 %), glucose 50 mg/ml (5 %) solution for injection or lactated Ringer’s solution.
Zdravilo Briviact lahko razredčite z naslednjimi raztopinami: natrijev klorid 9 mg/ml (0,9 %), glukoza 50 mg/ml (5 %) raztopina za injiciranje ali Ringerjeva raztopina z laktatom.
Briviact must not be used in patients who are hypersensitive (allergic) to brivaracetam, to other pyrrolidone derivatives (substances that are chemically similar to brivaracetam), or to any of the other ingredients.
Zdravila Briviact ne smejo uporabljati osebe, ki so preobčutljive za (alergične na) brivaracetam, druge derivate pirolidona (snovi, ki so kemično podobne brivaracetamu) ali katero koli drugo sestavino zdravila.
Briviact oral solution contains methyl parahydroxybenzoate, sodium and sorbitol
Zdravilo Briviact peroralna raztopina vsebuje metilparahidroksibenzoat, natrij in sorbitol
Briviact oral solution contains: methyl parahydroxybenzoate (E218) - this may cause allergic reactions (possibly delayed).
Zdravilo Briviact peroralna raztopina vsebuje: metilparahidroksibenzoat (E218) - lahko povzroči alergijske reakcije (lahko zapoznele);
Briviact solution for injection/infusion is used for a short amount of time when you cannot take Briviact orally.
Zdravilo Briviact raztopina za injiciranje/infundiranje se uporablja kratek čas, kadar zdravila Briviact ne morete jemati skozi usta.
Briviact tablets are packaged in blister packs supplied in cardboard boxes containing either 14, 56 or 14 x 1 or 100 x 1 film-coated tablets or in multipacks containing 168 (3 packs of 56) film-coated tablets.
Tablete zdravila Briviact so pakirane v pretisne omote, ki se nahajajo v škatlah, ki vsebujejo po 14, 56 ali 14 x 1 ali 100 x 1 filmsko obloženo tableto, ali v večkratnih pakiranjih, ki vsebujejo 168 (3 pakiranja po 56) filmsko obloženih tablet.
Briviact with alcohol
Zdravilo Briviact skupaj z alkoholom
Broadline can also be used to prevent heartworm disease for one month.
Prav tako se lahko uporablja za enomesečno preprečevanje srčnih glist.
Broadline is a veterinary medicine that contains four active substances: fipronil, (S)-methoprene, eprinomectin and praziquantel.
Broadline je zdravilo za uporabo v veterinarski medicini, ki vsebuje štiri zdravilne učinkovine: fipronil, (S)-metopren, eprinomektin in prazikvantel.
BROADLINE is not intended for use in dogs.
BROADLINE ni namenjen uporabi pri psih.
Broadline is used to treat cats with, or at risk of, mixed infestations by tapeworms, roundworms and external parasites (fleas, ticks and a burrowing mite called Notoedres cati).
Zdravilo Broadline se uporablja za zdravljenje mačk z mešanimi infestacijami s trakuljami, glistami in zunanjimi paraziti (bolhami, klopi, garjami vrste Notoedres cati) oziroma mačk, ki so izpostavljene temu tveganju.
Broadline must not be used in sick or recovering animals.
Zdravilo Broadline se ne sme uporabljati pri bolnih živalih ali med okrevanjem po bolezni.
BROADLINE spot- on solution
BROADLINE kožni nanos, raztopina
BROADLINE spot-on solution
BROADLINE kožni nanos, raztopina
Broadline treated cats were compared to cats treated with a spot-on product containing the worm medicines emodepside and praziquantel.
Mačke, zdravljene z zdravilom Broadline, so primerjali z mačkami, zdravljenimi z zdravilom za kožni nanos, ki je vsebovalo zdravili proti črvom emodepsid in prazikvantel.
Broadline was more than 90% effective in reducing lungworm larvae at 28 days after treatment and all treated cats showing respiratory signs (such as wheezing, persistent coughing and a runny nose) were clinically cured.
Zdravilo Broadline je pokazalo več kot 90 % učinkovitost pri zmanjšanju števila ličink pljučnega črva na 28. dan po zdravljenju, vse zdravljene mačke, ki so kazale dihalne motnje (sopihanje, trdovraten kašelj in izcedek iz nosu) so bile klinično ozdravljene.
Brochure for male patients
V brošuri za moške bolnike je treba navesti:
Brochure for women patients of childbearing potential and their partners
brošure za ženske v rodni dobi in njihove partnerje,
Brochure for women patients of childbearing potential and their partners
brošure za ženske v rodni dobi in njihove partnerje;
Brochure for women patients who are not of childbearing potential
brošure za ženske, ki niso v rodni dobi; brošure za moške bolnike.
Brochure on breakthrough pain
Brošuro o prebijajoči bolečini
broken bones
zlomi kosti.
Broken bones have been reported commonly (may affect up to 1 in 10 people) in women patients taking Paglitaz.
Pri bolnicah, ki so jemale Paglitaz, je bil pogosto (pojavijo se lahko pri največ 1 od 10 bolnic) opažen zlom kosti.
Broken bones have been reported commonly (may affect up to 1 in 10 people) in women patients taking Pioglitazone Krka.
Pri bolnicah, ki so jemale Pioglitazone Krka, je bil pogosto (pojavijo se lahko pri največ 1 od 10 bolnic) opažen zlom kosti.
Broken bones have been reported commonly (up to 1 in 10 people) in women patients taking pioglitazone.
Zlomi so bili pri bolnikih, ki so prejemali pioglitazon, zabeleženi pogosto (pojavi se lahko pri največ 1 od 10 bolnikov).
Bromfenac efficiently permeates the cornea of cataract patients: A single dose resulted in a mean peak aqueous humour concentrations of 79±68 ng/ml at 150-180 minutes after dosing.
Bromfenak učinkovito prehaja skozi roženico bolnikov s katarakto: enkratni odmerek je povzročil povprečno največjo koncentracijo v prekatni vodki 79 ± 68 ng/ml 150–180 minut po odmerjanju.
bromocriptine
z bromokriptinom,
bronchial asthma
bronhialna astma;
Bronchial haemorrhage
bronhialna krvavitev
Bronchial hyperreactivity
hiperaktivnost bronhijev
Bronchial spasm, Bronchitis, Epistaxis, Pneumonitis (see section 4.3), Pneumonia, Pulmonary congestion, Rhinitis, Sinusitis, Sore throat
bronhialni spazem, bronhitis, epistaksa, pnevmonitis (glejte poglavje 4.3), pljučnica, pljučna kongestija, rinitis, sinusitis, bolečine v grlu
Bronchial spasm, Cough, Pneumonia, Pneumonitis (see section 4.3), Sore throat
bronhialni spazem, kašelj, pljučnica, pnevmonitis (glejte poglavje 4.3), bolečine v grlu
Bronchiolitis (inflammation of small bronchi with breathing difficulties and wheeze in the chest, associated with cough and fever),
bronhiolitis (vnetje malih dihalnih poti (bronhiolov) s težavami z dihanjem in piskanjem v prsih, povezan s kašljem in z vročino),
Bronchiolitis, Candida nappy rash, Candidiasis, Cellulitis, Infectious croup, Viral gastroenteritis, Hand-foot-mouth disease, Influenza, Pseudocroup, Respiratory infection, Skin infection, Tonsillitis, Varicella+ ‡, Viral conjunctivitis
bronhiolitis, kandidiazni plenični izpuščaj, kandidiaza, celulitis, infekcijski krup, virusni gastroenteritis, virusna okužba dlani-stopal-ust (hand-foot- mouth disease), gripa, psevdokrup, okužba dihal, okužba kože, tonzilitis, norice+ ‡, virusni konjunktivitis
bronchitis
bronhitis,
Bronchitis
bronhitis;
Bronchitis (inflammation of the airways)
bronhitis (vnetje dihalnih pot)
Bronchitis (inflammation of the bronchi),
bronhitis (vnetje sapnic (bronhijev)),
Bronchitis Bronchiolitis
Bronhitis Bronhiolitis
Bronchitis Bronchopneumonia Dysphonia Hyperventilation Sputum Discoloured Throat irritation Pharyngitis
bronhitis bronhopnevmonija hripavost hiperventilacija obarvan sputum draženje žrela faringitis
Bronchitis viral
virusni bronhitis
Bronchitis*, cellulitis*, herpes simplex, influenza, oral fungal infection, sinusitis
bronhitis*, celulitis*, herpes simpleks, gripa, glivična okužba v ustih, sinuzitis
bronchitis,
+sinuzitis, hepatitis B1
Bronchitis,
inusitis,
Bronchitis, apnoea2 [see section 4.4 for apnoea in very preterm infants (≤ 28 weeks of gestation)]
bronhitis, apneja2 [glejte poglavje 4.4 glede apneje pri zelo nedonošenih (rojenih pred ali v 28. tednu nosečnosti)]
Bronchitis, candidiasis, cellulitis, herpes zoster, meningitis, nail infection, oral fungal infection, oral herpes, pneumonia, salmonella gastroenteritis, septic shock
bronhitis, kandidoza, flegmona, herpes zoster, meningitis, okužba nohtov, glivična okužba ust, ustni herpes, pljučnica, gastroenteritis, ki ga povzroča salmonela, septični šok
Bronchitis, common cold, low red blood cell count, swollen lymph glands, decreased appetite, difficulty in sleeping, anxiety, dizziness, migraine, numbness or tingling of the skin or of a limb, reduced sense of touch, eye inflammation, rapid heartbeat, flushing, cough, runny nose, chronic cough or wheezing (asthma), stuffy nose, sore throat, shortness of breath, diarrhoea, vomiting, abdominal pain, indigestion, contusion, itchingand hives, dermatitis, reddened skin, pain in your back, pain in your joints, pain in your arms or legs, muscle pain, muscle cramps, muscular weakness, chills, accumulation of fluid under the skin, influenza-like illness, pain or discomfort in the chest, lack of strength or feeling of weakness, indisposition, shaking chills.
bronhitis, prehlad, majhno število rdečih krvnih celic, otekle bezgavke, zmanjšan apetit, motnje spanca, tesnoba, omotica, migrena, odrevenelost ali mravljinčenje po koži ali v udih, zmanjšana občutljivost za dotik, vnetje očesa, pospešen srčni utrip, pordelost, kašelj, izcedek iz nosu, kroničen kašelj ali sopenje (astma), zamašen nos, vnetje žrela, zasoplost, driska, bruhanje, trebušne bolečine, motnje prebave, obtolčenine, srbenje in koprivnica, dermatitis, pordela koža, bolečine v hrbtu, bolečine v sklepih, bolečine v rokah ali nogah, bolečine v mišicah, krči v mišicah, mišična šibkost, mrazenje, kopičenje tekočine pod kožo, gripi podobni simptomi, bolečine ali neugodje v prsnem košu, nemoč ali občutek šibkosti, slabo počutje, drgetanje.
Bronchitis, cough, wheezing
bronhitis, kašelj, sopenje
Bronchitis, Gastroenteritis, Upper respiratory tract infection, Influenza, Sinusitis, Pharyngitis
bronhitis, gastroenteritis, okužba zgornjih dihal, gripa, sinuzitis, faringitis
Bronchitis, Herpes simplex, Nasopharyngitis, Upper respiratory tract infections, Sinusitis
bronhitis, herpes simpleks, nazofaringitis, okužbe zgornjih dihal, sinusitis
Bronchitis, sinusitis, gastroenteritis, tinea pedis
bronhitis, sinuzitis, gastroenteritis, tinea pedis
Bronchitis, sinusitis, herpes simplex (resistance), rhinitis Bacterial infection
bronhitis, sinusitis, herpes simpleks (rezistenca), rinitis
Bronchitis, sinusitis, herpes simplex (resistance), rhinitis Pneumonia§
bronhitis, sinusitis, herpes simpleks (rezistenca), rinitis pljučnica§
Bronchitis, sinusitis, herpes simplex (resistance), rhinitis Pneumonia§
faringitis*, virusna okužba* bronhitis, sinusitis, herpes simpleks (rezistenca), rinitis pljučnica§
Bronchitis, upper respiratory infection, oral candidiasis, herpes simplex, fungal, viral and bacterial infections
bronhitis, okužba zgornjih dihal, kandidaza v ustih, herpes simpleks, glivične, virusne in bakterijske okužbe
bronchitis, upper respiratory tract infection, sinusitis, urinary tract
bronhitis, okužba zgornjih dihal, sinuzitis, okužba sečil, gripa
bronchitis, upper respiratory tract infection, sinusitis, urinary tract infection, influenza
bronhitis, okužba zgornjih dihal, sinuzitis, okužba sečil, gripa
Bronchitis; gastroenteritis; viral infections; skin, eye and ear infections; pneumonia
bronhitis, gastroenteritis, virusne okužbe; okužbe kože, oči in očes; pljučnica
Bronchitol 40 mg capsules are presented in double aluminium blisters in cartons containing 10 or 280 capsules for initial dose and treatment use respectively.
Bronchitol 40 mg kapsule so v dvojnih aluminijastih pretisnih omotih v škatlah, ki vsebujejo 10 kapsul za začetni odmerek ali 280 kapsul za terapevtsko rabo.
Bronchitol 40 mg, inhalation powder, hard capsules Mannitol
Bronchitol 40 mg prašek za inhaliranje, trde kapsule manitol
Bronchitol capsules can only be used with the inhaler supplied in the pack.
Kapsule Bronchitol se lahko uporabljajo samo s priloženim inhalatorjem v pakiranju.
Bronchitol contains a medicine called mannitol which is a mucolytic agent.
Bronchitol vsebuje učinkovino, ki jo imenujemo manitol in je mukolitik.
Bronchitol has not specifically been studied in patients with impaired renal and hepatic function.
Zdravilo Bronchitol ni posebej proučeno pri bolnikih z okvarjenim delovanjem ledvic ali jeter.
Bronchitol is a powder for inhalation that is filled into capsules.
Zdravilo Bronchitol je prašek za inhaliranje, ki je napolnjen v kapsule.
Bronchitol is administered by the oral inhalation route using the inhaler provided in the pack.
Zdravilo Bronchitol se daje s peroralno inhalacijo z inhalatorjem, priloženim v pakiranju.
Bronchitol is breathed in (inhaled) as a powder from the capsule using the inhaler supplied in the pack.
Zdravilo Bronchitol se vdihne (inhalira) kot prašek iz kapsule z inhalatorjem, priloženim v pakiranju zdravila.
Bronchitol is not likely to affect your ability to drive or use any tools or machines.
Zdravilo Bronchitol verjetno ne bo vplivalo na vašo sposobnost vožnje in upravljanja s stroji.
bronchoconstriction and anaphylaxis (a severe, whole-body allergic reaction), constant cough,
bronhokonstrikcija in anafilaksija (huda alergijska reakcija po vsem telesu), neprekinjen kašelj,
Bronchodilator therapy, such as salbutamol
zdravljenje z bronhodilatatorjem, kot je salbutamol
bronchodilators (beta-2 agonists) which are used to treat asthma
bronhodilatatorje (agoniste beta-2), ki se uporabljajo za zdravljenje astme
bronchodilators (beta-2 agonists) which are used to treat asthma ramipril, lisinopril and enalapril (ACE inhibitors) used to treat high blood pressure
bronhodilatatorje (agonisti adrenergičnih receptorjev beta-2), ki jih uporabljamo za zdravljenje astme. ramipril, lizinopril in enalapril (zaviralci ACE), ki jih uporabljamo za zdravljenje visokega krvnega tlaka.
bronchodilators (beta-2 agonists) which are used to treat asthma.
bronhodilatatorje (agonisti beta-2), ki se uporabljajo za zdravljenje astme;
bronchodilators (β-sympathomimetics) for the treatment of bronchial asthma. iodinated contrast agents (which you may receive while having X-ray) or alcohol-containing medicines, see 'Warnings and precautions'.
bronhodilatatorje (beta simpatomimetiki) za zdravljenje bronhialne astme; jodirana kontrastna sredstva (ki jih lahko prejmete pri rentgenskem slikanju) ali zdravila, ki vsebujejo alkohol, glejte 'Opozorila in previdnostni ukrepi‘.
bronchodilators, used to treat asthma and other lung-related problems:
bronhodilatatorje, ki se uporabljajo za zdravljenje astme in drugih težav, povezanih s pljuči:
Bronchodilators;
bronhodilatatorji,
Bronchospasm
bronhospazem
bronchospasm (0.2% vs 0%), exertional dyspnoea (0.5% vs 0.5%)
bronhospazem (0,2% v primerjavi z 0%), dispneja pri naporu (0,5% v primerjavi z 0,5%)
Bronchospasm (breathing difficulties),
bronhospazem (težave z dihanjem),
bronchospasm (predominantly in patients with pre-existing bronchospastic disease)
bronhospazem (zlasti pri bolnikih z obstoječo boleznijo, ki vključuje bronhospazem)
bronchospasm (predominantly in patients with pre-existing bronchospastic disease), asthma
bronhospazem (zlasti pri bolnikih z obstoječo boleznijo, ki vključuje bronhospazem), astma
Bronchospasm (predominantly in patients with pre-existing bronchospastic disease).
bronhospazem (predvsem pri bolnikih z obstoječo bronhospastično boleznijo)
Bronchospasm (sudden constriction of the muscles in the walls of the small airways) and wheezing (see also section 2 “Warnings and precautions”)
Bronhospazem (nenaden krč mišic v steni majhnih dihalnih poti) in zasoplost (glejte tudi poglavje 2 »Opozorila in previdnostni ukrepi«).
bronchospasm (wheezing or coughing), hives*.
bronhospazem (piskanje ali kašelj), koprivnica
Bronchospasm can occur with inhalation of medicinal products and has been reported with TOBI Podhaler in clinical studies.
Pri inhalaciji zdravil lahko pride do bronhospazma, o katerem so poročali tudi pri uporabi zdravila TOBI Podhaler v kliničnih študijah.
Bronchospasm may develop particularly in patients with asthma.
Zlasti pri bolnikih z astmo se lahko razvije bronhospazem.
Bronchospasm Nasal dryness
bronhospazem suhost nosu
Bronchospasm Respiratory depression
bronhospazem respiratorna depresija
Bronchospasm should be treated with a bronchodilator or as medically appropriate.
Bronhospazem je treba zdraviti z bronhodilatatorjem ali na drug primeren način.
Bronchospasm*
bronhospazem
Bronchospasm* (see section 4.4) / Wheezing
bronhospazem* (glejte poglavje 4.4) zasoplost
Bronchospasm*, hypoxia*, dyspnoea*, chest discomfort*, pharyngolaryngeal pain*, cough*, nasal congestion*
bronhospazem*, hipoksija*, dispneja*, nelagodje v prsih*, faringolaringealna bolečina*, kašelj*, zamašenost nosu
bronchospasm,
bronhospazem,
bronchospasm,
prostora